Sudeep Pharma Ltd.

₹586.45

-24.8 (-4.1%)

SUDEEPPHRM Share Price

Pharmaceuticals & Biotechnology

As on January 16, 2026

Sector

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 0 Cr

P/E Ratio41.11

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	593.46	Bearish
10-DMA	590.89	Bearish
20-DMA	613.18	Bearish
50-DMA	---
100-DMA	---
200-DMA	---

Historical Performance

1 Year

N/A

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	5,020	4,593	4,287	3,430	2,151
Total Expenditure	3,110	2,768	3,386	2,756	1,710
Other Income	93	61	95	74	34
Operating Profit	2,003	1,886	997	748	475
Interest	69	47	58	17	10
Depreciation	106	90	79	45	35
Profit Before Tax	1,828	1,748	860	686	430
Consolidated Net Profit	1,387	1,332	623	502	333
Adjusted EPS	14	14	6	5	3

Compounded Sales Growth

10 Years:32.5

5 Years:32.5

3 Years:7.9

TTM:1.8

Compounded Profit Growth

10 Years:50.4

5 Years:50.4

3 Years:22.6

TTM:0.8

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:N/A

Return on Equity

10 Years:N/A

5 Years:3.4

3 Years:6.4

last year:14.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	120	14	14	14	14
Total Reserves	4,811	3,546	2,219	1,619	1,128
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	490	204	255	335	187
Other Current Liabilities	253	252	708	15	186
Short Term Borrowings	853	541	518	555	170
Total Liabilities	7,168	5,136	4,196	3,438	2,127
Capital Work in Progress	882	447	260	81	240
Long Term Loans & Advances	148	131	51	24	25
Currents Investments	1	1	30	---	---
Short Term Loans and Advances	391	444	481	197	72
Total Current Assets	4,241	2,754	2,300	1,966	995
Total Assets	7,168	5,136	4,196	3,438	2,127
Adjusted Book Value	50	37	23	17	12

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 41.11, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered price CAGR data is unavailable.
The stock carries a high beta of 1.6, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹2003 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹5020 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 757540.5

No. of Shares: 1292 (Approx)

Performance:-24.2%

P/L: ₹-242459.5

NIFTY Performance: 10.7%

1 day Top Gainers